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STATEMENT OF THE PROBLEM
Recent interest in the use of oral contraceptive agents by humans has
been high.

Their widespread popularity as a convenient and efficient means

of birth control, and as a therapeutic regime for various gynecological
diseases has proven a stimulus sufficient to permeate the literature with
documentation of the direct effects of these drugs on the welfare of the
human organism.

However, extensive research concerning drug effects on the

natural course of bacterial disease has only recently begun to appear.
It

remain~

then for the researcher to leave no corner darkened in an

attempt to delineate effects of these drugs insofar as they hold practical
importance for their human users.

The purpose of this work is a clarifica-

tion, through review and experimentation, of the ability of a specific
contraceptive agent to modify the host-parasite relationship as it exists
in human bacterial disease.

1.

INTRODUCTION
Oral contraceptives by almost any medical yardstick are a new and largely
unknown quantity.

They represent the answer of twentieth century scientific

know-how and technology to an anguished cry for help from a burgeoning world
population.

These drugs have brought to a close with door slamming finality

a more traditional period of contraception through the promise of a new era

.

hallmarked by efficiency, low cost, simplicity and ease of administration,
and safety.

Of these factors only the latter has threatened to turn the

panacea into a Pandora's box.
Minor side effects accompanying the use of contraceptive drugs are
common and

inc~ude

gastrointestinal disturbance, malaise, menstrual irregu-

1arities, rash, hirsuitism, alopecia, weight gain and chwasma to mention
only a few (40).

Possible complications of an inherently more serious nature

include potential for the production of thromboembolism, and carCinogenesis.
Despite lingering doubts it is estimated that in Australia and New
Zealand 20% of women of reproductive age use oral contraceptives, whereas
in the United States 12% are users and in the United Kingdom 3% (18).

Pro-

jection of such figures calls for a dramatic increase in worldwide uti1ization of oral contraceptives to the point that between 20 and 40 million
of the world popUlation will control their fertility through this method
by the year 1980 (18).

Such use will no doubt be facilitated by development

of new drugs with greater potency and fewer adverse effects.

2.

In addition it should be remembered that oral contraceptive drugs need
not be used solely for family planning for they have proven a welcome addition to the therapeutic arsenal of the gynecologist.

Therapeutic efficacy

has been claimed not only in fertility control but in the treatment of such
disease states as amenorrhea, dysmenorrhea, endometriosis and functional
uterine bleeding.

The value of contraceptives in the treatment of such

conditions as menopausal syndrome, acne, chronic vulvar infections and psychiatric disorders remains a subject for further research (19).
Of the oral contraceptive drug combinations in present day use a popular
and representative example in Enovid.

This drug consists of the synthetic

progestogen Norethynodrel (17a ethynyl 17 hydroxy 5(10) estrene 3 one) and
the synthetic estrogen Mestranol (17a ethynyl estradiol 3 methyl ether).
Although these compounds are characterized biologically through differing
effects their basic structure is remarkably similar (53).

In fact, struc-

tural dissimilarities are limited to ring A of the steroid nucleus and to
the chemical grouping substituted on carbon atom 3.

Such a close correlation

is reflected functionally since it is known that Norethynodrel, while having
a high progestational activity possesses as well a low inherent estrogenic
activity (6).
In view of chemical details, then, it appears that a consideration of
effects of steroid compounds in general is a necessary first step toward
understanding the action of Enovid.

The high electron affinities of steroids,

a property unusual among organic compounds, may be an indication of their
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ability to participate in or control biological oxidative processes (13).
One of the earliest observed effects of steroid hormones in vitro upon
enzymatic systems was found to be the general inhibition of respiration
effected by a variety of steroids in preparations from diverse sources (48).
Specifically, it has been observed that steroid hormones inhibit the reduction of cytochrome C by NADH2 in intact mitochondria from rat liver cells.
In addition, mitochondrial pa:ticu1ate preparations are known to exhibit
steroid induced permeability changes.

It is possible that an increase in

permeability in mitochondrial membranes permits a loss of the NAD necessary'
for respiratory functions.

In rat liver mitochondria at least, steroid

inhibition of respiration was found to be reversible upon the addition of
NAD to the media (48).
In a more immediate sense glucocorticoids are believed to function
as passive antagonists of a stress activated intrinsic microcirculatory
dilator and thus to oppose relaxation of microvascular sphincters.

At the

site of irritation dilator synthesis is increased and all small vessels are
open.

Corticoids by closing sphincters suppress the early hyperemia thereby

preventing development of later phases of the inflammatory reaction.

In

the absence of corticoids mild stress activation of dilator synthesis leads
to excessive opening of capillaries while greater activation leads to pooling
of blood and circulatory failure (41).

More recently such circulatory

dilators have been identified and. characterized.

Kinin,s are naturally

occurring vasoactive polypeptides thought to be the mediators of the acute
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inflammatory response.

They are released from a plasma protein substrate

by glass activated plasma enzymes (kallikreins) or by isolated intact granulocytes.

Cortisol at a concentration of 2.5 x 10- 5 M was found to prevent

the release of active kinin by granulocytes or contact with glass.

Deoxy-

corticosterone, progesterone and etiocholanolone in comparable concentrations
were found significantly less effective in preventing kinin release (41).
Cortisol also partially inhibited the release of kinin by purified urinary
kallikrein.

Thus certain steroids may possess anti-inflammatory effects by

virtue of their ability to inhibit the release of plasma kinins.

They seem

able also to prevent interaction between activated kallikrein and its substrate (11).
Compounds 'that are able to alter the course of inflammation and affect
such basic processes as cellular respiration might well be expected to influence the host-parasite relationship as it exists in human infectious disease.
Due to the practical implications of such a contingency the effect of glucocorticoids on disease processes has been studied in detail.

Both adreno-

corticotropic hormone (ACTH) and cortisone have been found to depress the
resistance of laboratory animals to infectious agents, activate foci of
latent infection and render animals susceptible to intection by ordinarily
non-pathogenic flora.

Infected animals may succumb to smaller doses of

infective agent than do animals not receiving

ho~mones;

conjunction With antibiotics the &teroids generally
of a given dose of antibiotic.

and, when given in

red~ce

the effectiveness

Factors induced by steroid administration

s.

which may play a role in decreased host resistance include a decrease in the
local inflammatory response, increased multiplication of the pathogen and
inhibition of phagocytosis and the capacity of the reticuloendothelial system
to fix or remove bacteria and their toxins from tissue (24).

Steroids reduce

the rate of antibody synthesis and it has been found that the bactericidal
capacity of leucocytes obtained from the peritoneal exudate of rats pretreated for 3 days with

intr~uscular

injections of cortisol displayed an

impaired capacity to kill phagocytized organisms (3). 'In addition, widespread dissemination characteristic of hormone treated animals may in some
instances reflect the inhibitory effect of cortisone on the action of hayluronidase (24).

Mineralocorticoids apparently have less drastic erfects on

the microbial world although it is known that deoxycorticosterone may markedly
inhibit the growth of Neurospora crassa in a highly specific manner.

In

fact, growth of all Gram-positive bacteria, yeasts and molds are significantly
affected by tnis compound (26).
The effects of pregnancy on various disease states may be the

res~lt

of

intrinsic physiologic change related to the economy of endocrine hormones
whose concentrations rise dramatically in the gravid female (14).

As a

result these compounds, notably estrogens and progestogens, have been extensively studied with respect to their effect on pathogenic microorganisms.
Casas-Campillo demonstrated that 21-31 dimethoxyprogesterone effectively
inhib£ted the growth of Curvularia lunata and Trichophyton mentagrophytes.
Fungistatic effects were found to decrease with increasing complexity of
"
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the modifications on carbon atom 21 (10).

Progesterone has been shown to

have a bacteriostatic effect on staphylococci in vitro which correlated well
with a significant reduction in the oxygen uptake (55).

Yotis has carried

this work a step farther by demonstrating that Norethindrone, a synthetic
progestogen, has in vivo effects serving to protect infected animals against
the formation of dermal lesions (54).

Some workers feel that the inhibitory

capacity of the sex hormones depends upon specific functional groups or
chemical properties rather than merely on the general features of steroid
structure (46).

Information is accumulating to show demonstrable sex dif-

ferences in respect to immune responsiveness; the female being more responsive than the male.

In addition there is evidence that immune responsiveness

is lower in the pregnant female ot most species

inc1udin~

humans (16).

In

this regard it has been found that progestational agents increase the hazard
from anapnylactic shock in rats.

Hydroxyprogesterone caproate (De1a lutin)

and 6a methyl 17 hydroxyprogesterone acetate have been found to delay the
rejection of skin grafts in rabbits (51).
The estrogenic hormone estrone increases the resi.stance of the castrated
rabbit to vaccinia infection (45).

Estradiol, however, has been found by

other investigators to shorten survival time of animals infected with certain
species of Aspergillus.

This effect was correlated with leukopenia and

relative neutropenia (31).

Lurie found that in

~xperimenta1

infections with

Mycobacterium tuberculosis, estrogens exerted a retarding effect on the
growth of the lesion at the site of inoculation, diminished the extent of

7.

the disease in internal organs and suppressed its dissemination throughout
the body (30).

Conversely, the gravid state in white mice has been shown to

increase their susceptibility to infection with streptococci (51).
The effects of estrogen on the function of the reticuloendothelial
system are well documented.

It appears that the estrogenic molecule has

two unrelated biological functions - modification of sexual organs and stimulation of the reticuloendothelial system (34).
eftect on the primary immune response.

Estrogens exert an adjuvant

Their ability to increase phagocytic

ability, elevate serum gamma globulin levels and protect experimental animals
against severe infection provide strong argument for a generalized arousal
of body defenses.

Several substances, including endotoxins, lipopolysac-

charides, lipid A and zymosan, are also capable of this action; but to date,
the strongest reticuloendothelial system stimulants appear to be estrogens
both natural and synthetic (35).

Cortisone has been shown to act as an

antagonist to estrogen in that it depresses phagocytic ability, the total
and difterential white blood cell count and the serum levels of gamma

~lo

bulin.In fact, if cortisone and estrogens are administered separately but
simultaneously at separate sites, the depressant activity of cortisone is
prevented and considerable stimulation of phagocytic activity occurs (17) •.
Other reticuLoendothelial depressants include prednisone, 4 hydroxy tetraphenylmethane, cholesterol, ergosterol, stilbene (33) and ethanol (2).
The basic mode of action in

~urrently

marketed

ora~

contraceptives is

similar in all - the inhibition of ovulation and the initiation of periodic
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breakthrough bleeding.

However, the potentiality of these compounds to

affect human consumers is by no means limited to prevention of pregnancy.
In an attempt to completely consider the drug modified human in his context
as bacterial host, a brief review of metabolic effects is worthy of mention.
It

~s

now well established that the oral contraceptives

inn~D~t

ovulation

predominantly at the pituitary level where they interfere with the synthesis
and release of 1utenizing hormone.

After cessation of therapy resumption of

ovulation is prompt, with return of pituitary function within 6 to 8 weeks.
Administration of Norethynodrel (1-5 mg per 100 g of body weight) to
female white rats was found to produce striking effects in the adrenal glands.
Histochemically, lipid was found depleted from the cortical zones while tne
parenchymal cells of the zona glomeru1osa became smaller.

Significant lipid

depletion occurred in the zona fasicu1ata and reticularis after only 2 days
of treatment (5).

Total weight of the glands was found to be increased over

that of controls.

Corticosterone assays performed on adrenal cortices and

plasma from treated animals indicated increased concentrations of hormone (6).
In humans oral contraceptives have been observed to produce increased cortisol
binding by serum proteins (23).

Low levels of urinary 17 hydroxysteroids

have been accounted for by Leach and Margulis (25) who observed a variable
suppression of pituitary ACTH in response to treatment with progestin.
Studies of thyroid function reveal that the majority of women taking
oral contraceptives show increased blood levels of thyroxine binding globulin (TBG) as well as protein bound iodine (PBI) with a stmultaneous decrease

9.

in the T3 RBC uptake.
occasion.

the PBI may rise into the hyperthyroid range on

These thyroid effects are probably secondary to estrogen induced

increase of the binding proteins, for in no instance, has clinical evidence
of hyperthyroidism been reported.
There is no good evidence that Enovid alters directly the diabetic
state.

However, in a few cases, some degree of difficulty in the management

of diabetic patients has been reported in connection with Enovid therapy.
One study has indicated that a high percentage of women taking Enovid for
fertility control have impaired glucose tolerance.

The incidence of abnormal

test results is greater in women with a family history of diabetes than in
those without such a history.

It seems reasonable to associate this change

in glucose tolerance with the "pseudo pregnancy" (15) induced by the drugs
since pregnancy has long been known as an efficient screening test for preclinical diabetes mellitus.

Viewed in this light it is possible that those

women exhibiting impaired glucose tolerance during Enovid therapy and having
a positive family history should be carefully followed in anticipation of
the onset of overt diabestes mellitus.

Specifically, this diabetogenic

effect seems to be due more to the progestogenic component of the contraceptive combination.
Liver function is yet another parameter subject to alteration by the'
oral contraceptives.

These drugs may produce in certain patients clinical

signs ;of jaundice and modifications in various tests of liver function indicative of biliary stagnation and hepatocellular damage (40).
"
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These changes

,

are apparently mild and reversible on discontinuation of hormonal therapy.
Women who have had cholestasis of pregnancy or familial, congenital or acquired defects of biliary secretion are most vulnerable (1).

The capacity

of certain synthetic steroids to induce abnormalities of liver function has
been attributed to the unnatural structural configurations or chemical substitutions that characterize these compounds.

For instance, the natural

hormone progesterone has not been shown to have this action.

The synthetic

progestogens, however, have certain functional groups (e.g. the 17 alkyl
groups) which are known to confer hepatotoxicity (23).

In

ad~ition,

the

natural hormone estradiol and related synthetic estrogens consistently impair
the ability of the liver cell to excrete the dye bromsulpthalein -- a sensitive test of ' hepatocellular function.

The possibility of a potentiating

effect of estrogenic and progestogenic compounds on liver function has not
yet been thoroughly investigated (23).

On a subcellular basis Norethynodrel

was capable of producing alterations in certain hepatic drug metabolizing
systems as measured in vitro.

It should be noted that metabolic pathways

most affected were those in which hydroxylated or oxidized products were
formed.

The nature of this inhibition appears to be competitive and may

indicate that liver microsomal enzymes which catalyze certain aliphatiC or
aromatic hydroxyl at ions of drugs and foreign compounds may also catalyze
hydroxylation of progestogenic steroids.
lyze nydroxylations of
been forthcoming.

androgenic~

Evidence that such systems cata-

estrogenic and

corti~osteroi~s

has already

It is of interest that Norethynodrel seems to stimulate
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only certain drug metabolizing enzymes and that progesterone does not have
this action (22).

Electron microscopic studies of tissue obtained at liver

biopsy from women taking oral contraceptives showed consistent mitochondrial
changes as evidenced by considerable enlargement and irregularity of shape.
The normal inner membrane was partially replaced by systems of laminae
oriented parallel to the long axis of the mitochondrion (4).
Possibly a less significant metabolic effect with regard to serum copper
levels has been reported by Carruthers (9).

He was able to demonstrate a

marked increase in the serum copper and ceruloplasmin levels in 25 female
subjects taking oral contraceptives.

The correlation between copper and

ceruloplasmin concentration together with the finding of normal urine copper
levels in 10 subjects suggested that the increased serum copper was due to
increased ceruloplasmin synthesis.
In a study of 36 patients receiving oral contraceptives, Strauss and
Pochi (41) found a significant decrease in sebum production.

Separate admin-

istration of drug components revealed the effect primarily due to the estrogen.

Suppression of sebaceous gland activity was found to be directly

correlated with improvement in acne vulgaris.

Indeed, recent clinical

trials indicate striking effects of contraceptive drugs on dermal abcesses
complicating acne (37).
Of all the possible effects attributable to oral contraceptives the
tendency to thromboembolic
and potentially lethal.

phenome~a

has remained one of the most enigmatic

Although there have been many studies by competent
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investigators the results have proven conflicting and divergent.

It is

known that certain of the clotting factors such as fibrinogen and factors
VII to X are elevated in women consuming oral agents on a long term basis
(12,32).

Unfortunately, even though many of the factors in the blood con-

cerned with clotting can be ascertained, their elevation is not a measurement
of hypercoagulability.

For example, although fibrinogen and factors VII to X

are elevated in pregnancy, thromboembolism occurs most commonly in the
puerperium when levels of these factors have returned to normal.

At present

all that may be said is that available statistics show no clear cut relationship between contraceptive administration and the production of thromboembolism.

Indeed the Food and Drug Administration's advisory committee on

obstetrics and 'gynecology has recommended a long term, carefully designed
epidemiologic study to shed light on this problem.
Other long term effects presently being scrutinized include the possible
participation in tumorigenesis •. In experimental animals there is abundant
evidence for such a role.

Ovarian granulosa cell tumors have been induced

in BALB mice by administration of 19-nor progesterone (21), progesterone
(27), Norethindrone and Norethynodrel (28).

The neoplastic faculty of the

synthetic 19 nor-progestogenic steroids appears superior to that of the
natural progesterone.

Progesterone and 19 nor-progesterone contraceptives

have also been shown capable of producing uterine malignancy, characteristically a sarcoma, in

experimenta~

animals.

Similar tumors have been found

in women receiv{ng 19-nor progestogenic agents (29).
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Estrogenic compounds have also been implicated in the production of
neoplasia involving cervix, endometrium, ovary, breast, testicle, pituitary,
kidney and bone marrow in laboratory animals (1).

However, it must be

remembered that animal studies in which certain susceptible strains and
species are used and excessive dosages are employed, cannot be readily and
accurately applied to the situation regarding human beings.

Such data does

serve to inject a note of cau;ion and emphasizes the need for good, long
term statistical studies.

14.

MATERIALS AND METHODS
Cultures.

The following microorganisms were used -- Staphylococcus

aureus serotypes 1-13, Smith Diffuses strain, Rose strain and strain 209.
These organisms were kept in stock at 4 C on tryptic soy agar (Difco) slants
in screw capped tubes.

Transfer to a new slant was made every four weeks.

Cultures were checked periodically for morphology, anaerobic utilization of
glucose and mannitol, free and bound coagulase, pigmentation and gelatin
liquefaction by accepted microbiologicai procedures (44).

In addition,

inocula were screened before and after individual experiments for contaminants by Gram staining and the production of coagulase as measured by its

.

ability to clot citrated plasma (Difco) .
Hormone .. Powdered pure Norethynodrel and Mestranol were obtained from
the Searle Drug Company.

Fresh solutions were prepared by dissolving 20 mg

of Norethynodrel in 10 ml of 95% ethanol and immediately transferring 1 ml
of the solution to 49 ml of tryptic soy broth (Difco) in 300 ml nephelometric
flasks, yielding a final concentration of 40 ~g hormone per ml of growth
medium.

Control flasks received 1 ml of 95% ethanol.

were then sterilized by autoclaving.

Both sets of flasks

For animal inoculation 10 mg of

Norethynodrel and 5,mg of Mestranol were dissolved together in 10 ml of
95% ethanol.

Of this solution .1 ml was mixed with 9.9 ml of sterile saline

to arrive at a solution containing 10
of Mestranol.

~g/ml

of Norethynodrel and 5

~g

per ml

Mice were injected intraperitoneally with .25 ml of the above
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solution.

Control animals received 0.25 ml of 1% ethanol in saline by the

same route and at the same time.
When animals were injected intravenously with bacteria and hormone
simultaneously the hormone was dissolved in ethanol and a 1% solution prepared as described previously.

~

aureus previously grown at 37 C for 18 hr

was then harvested by centrifugation and added to the solution.

Adjustment

to the desired bacterial density was accomplished by subsequent dilution with
hormone solution.

At no time were bacteria suspended in hormone solution

for periods greater than one hr prior to use.
Growth studies.

Cells used in growth studies were .grown in 10 ml of

3% tryptic soy broth (Difco) at 37 C for 18 hr and harvested by centrifugation.

A smooth suspension was prepared by manual shaking for 1 min and

was then adjusted with sterile saline (0.9%) to 10 Klett units by use of a
No. 42 filter in a Klett-Summerson photoelectric colorimeter.

This bacterial

density corresponded to approxUnately 7 x 106 viable cells per mI.

Each

nephelometric flask was inoculated with 1 m1 of the above suspension and
incubated aerobically in a walk-in incubator on a rotary shaker at 37 C, or
anaerobically in a stationary carbon dioxide incubator at a similar temperature under 2.5 atmospheres of pressure (C02),
Growth was estimated turbidimetrically at varying time intervals using
the Klett-Summerson photoelectric colorimeter and previously prepared standard curves.
or minus 0.3

Under these
~g

conditi~ns

1 Klett unit was equivalent to 1.5 plus

dry weight of cells per mI.
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Animal work.

All mice and rabbits were obtained from Abrams Small Stock

Breeders, Chicago, Illinois.

The mice were maintained on a diet of Rockland

Mice Pellets and the rabbits on Dixie Rabbit Pellets.

All animals received

food and tap water ad libitum.
White Swiss female mice, each weighing between 18 and 22 g, were used
in all work.

These mice were prepared by intraperitoneal inJection of a

0.25 m1 volume of solution containing 2% ethanol and varying concentrations
of hormone prepared as above.

On the fourth day the mice received a bacterial

suspension in a solution containing hormone and adjusted to 450 Klett units.
This suspension was administered through the dorsal tail vein in a total
volume of 0.25 m1 which had been adjusted to the desired hormone concentration.

Mice were observed for three days after infection and the number of

deaths on each day recorded.
New Zealand female rabbits, 6 months old and weighing between 2.7 and
3.2 kg, were used in all experiments.

These animals were prepared by shaving

bilateral paravertebral areas of skin approximating 9 sq. in,.

Subseque~t1y

they received at this site daily subcutaneous injections of varying quan:tities of hormone for periods of between 5 and 14 days.
challenged by injecting into the marginal ear vein
total volume of 1 ml of hormone solution.

~

They were finally

aureus suspended in a

The amount of hormone administered

was equivalent to that given on any previous

ind~vidua1

subcutaneous injec-

tion. ; Total white blood cell counts were made by the use, of a conventional
white cell counting chamber, pipette and acetic acid (2.5%) diluent.
'.
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,

Relative quantities of neutrophils and lymphocytes were estimated under the
oil immersion lens of the light microscope using Wright's stain and phosphate
buffer (44).

The first 100 white cells were counted at random in three

widely separated areas of the same slide and standard hematological criteria
based on size, shape, cytoplasmic granulation and nuclear morphology were
used to identify various cells.

Blood counts, both before and after bacterial

challenge, were compared with suitable control values.

In addition, samples

of whole blood were aseptically drawn at various periods after infection from
the marginal vein of the ear opposite to that used in inoculation.

These

samples were then diluted in sterile saline in a ten-fold continuum.

Pour

plates were made with 0.5 ml of the appropriate dilutions using tryptic soy
agar (Difco) and placed in a 37 C stationary

inc~bator

for 48 hr.

The

number of colonies was then counted and the results expressed as colony
forming units per ml of blood.
Bacterial counts.

Mice were selected at random at 2, 4, 6, 18 and 24 hr

after intravenous infection and sacrificed with ether.

Utilizing sterile

techniques the spleen, kidney, lungs and liver were excised and homogenized
for 1 min with a Contorque power unit and 10 m1 tissue grinders (Thomas
teflon pestle model).

The resulting homogenate was then prepared by serial

ten-fold dilution in sterile saline (0.9%) and plate counts of viable organisms made as described above.

Prior to homogenization organs were immersed

in sterile saline (0.9%) and the volume of tissue estimated by observing the
displacement of fluid in calibrated vessels.

Results were expressed as

colony forming units per organ and per ml of tissue.

18.

,

In all studies outlined above adequate controls were maintained.

In

animal work the drugs were administered in dosages calculated to approximate
as nearly as possible on a per unit weight basis those dosages routinely
administered to human beings.

19.

RESULTS
Growth studies.

Turbidimetric assessment of the in vitro growth of

S. aureus indicated a strong inhibitory action of Norethynodrel being most

noticeable in the early or lag phase of the growth curve and persistent to
some extent over a period of 8 hr (Table 1).

It should be noted that

Norethynodrel in dosage limited only by its solubility (40

~g

per ml) evi-

denced a dose response relationship approximating linearity over the time
period studied.

After 8 hr of growth the inhibitory effect was found to

decrease rapidly until at 12 hr in almost all instances no significant difference was discernible between flasks containing the hormone and the controls.
The effect of Norethynodrel on the in vitro growth of

~

aureuS in

tryptic soy broth with regard to size of inoculum is emphasized
Norethynodrel (40

~g

in Table 2.

per ml) produced an inhibitory effect on growth at an,

initial inoculum of 0.1 ml of 10 Klett units, much as in the first table.
By varying bacterial density in the initial inoculum in 'an increasing manner
growth curves were obtained which tended to confirm the inhibitory effect
of Norethynodrel.

Moreover it appeared that a larger inoculum size did not

change the bacteriostatic effect while accelerating both its appearance and
disappearance in the course of bacterial growth, a simple skewing of the
curve to the left.
In an attempt to identify the specific portion of the growth curve at
which Norethynodrel exerted its maximal effect the hormone was added to each
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TABLE 1
EFFECT OF NORETHYNODREL ON THE GROWTH OF
STAPHYLOCOCCUS AUREUS IN TRYPTIC SOY BROTH
Average Klett readings at varying
hormone concentrations

o I-Lg/ml

Hours of growth

20 j..Lg/ml

40 j..Lg/ml

3

2.3

0.54

0.46

4

4.9

1.2

0.9

6

44.0

30.0

18.0

8

113.0

94.0

73.0

~

Inoculum:

0.1 ml of a suspension containing 10 Klett units
of

~

aureus (serotypes I-XIII, strain Rose, strain

Smith and strain 209).
Incubation:

Rotary shaker at a constant temperature of 37 C.

Results:

Average of values obtained with serotypes I-XIII,
strain Rose, strain Smith and strain 209.
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TABLE 2
EFFECT OF NORETHYNODREL ON THE GROWTH OF
STAPHYLOCOCCUS AUREUS IN TRYPTIC SOy BROTH
WITH REGARD TO THE SIZE OF INOCULUM
Size of Inoculum (Klett Units)
10
Hours of
Growth

Control

200

100
Hormone

Control

Honnone

Control

Hormone

3

5

0

30

16

50

28

4

20

8

56

26

110

80

6

75

48

128

101

191

170

8

115

95

170

160

246

245

Inoculum:

0.1 ml of a suspension of

~

aureus (serotypes I, II, III)

with a variable bacterial density as indicated above.
Incubation:

Rotary shaker at a constant temperature of 37 C.

Hormone:

Norethynodrel adjusted to a concentration of 40

Results:

Expressed in Klett units of bacterial density at various
time periods after inoculation.

Each result is the average

value obtained with serotypes I, II, III.
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~g/ml.

,

of several flasks at varying time intervals after inoculation with S. aureus.
It may be seen in Table 3 that each addition was effective in producing a
strong inhibition of bacterial growth up to 7 hr after inoculation with
S. aureus.
In view of the fact that any drug exerting effects on a living organism
must do so in a millieu of other chemically active substances, growth studies
were conducted utilizing Norethynodrel in combination with another steroid
hormone.

The presence in the media of such compounds as estradiol, testo-

sterone, deoxycorticosterone, Sa-pregnane, pregnenolone and progesterone in
concentrations of 20
nodrel.

~g/ml

was not found to modify the action of Norethy-

The situation was different, however, with regard to Norethynodrel

and hydrocortisone.
Norethynodrel" (20

~g

Table 4 illustrates the fact that a combination of
per ml) and hydrocortisone (20

~g

per ml) effected

bacteriostasis to a greater degree than either compound alone at a similar
concentration.

Thus, a synergistic effect of these steroidal compounds, .

one upon the other is noted.
The fact that the growth inhibition induced by Norethynodrel is not a
lasting one, but is dependent upon the continued presence of the compound
in the media, is illustrated in Table 5.

Bacteria were incubated in broth

containing hormone at a concentration of 40

~g

per ml for a period of 18 hr.

The organisms were then harvested, washed and used as inocula for hormone
and control flasks prepared as in ,previous studies.

Results reveal no dif-

ference in the subsequent growth or growth inhibition using as inocula
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TABLE 3

EFFECT OF NORETHYNODREL ON THE GROWTH OF
STAPHYLOCOCCUS AUREUS IN TRYPTIC SOY BROTH
WITH REGARD TO THE Tn1E OF ADDITION OF HORMONE TO MEDIA

Hour of
growth

Control

Hormone
added at
2 hr

Hormone
added at
4 hr

Hormone
added at
6 hr

Hormone
added at
7 hr

2

0

0

0

0

0

4

20

0

18

20

20

6

70

40

30

70

70

8

280

242

204

241

275

Inoculum:

0.1 m1 of a suspension containing 10 Klett units of
S. aureus (serotype III).

Incubation:

Rotary shaker at a constant temperature of 37 C.'

Results:

Expressed in Klett units of bacterial density at various
time periods after inoculation.
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TABLE 4
POTENTIATION BY HYDROCORTISONE OF THE EFFECT OF NORETHYNODREL ON
THE GROWTH OF STAPHYLOCOCCUS AUREUS IN TRYPTIC SOY BROTH

Klett readings at various times (hr)
Hormone

2

6

9

Control (Ethanol - 2%)

3

29

80

0

3

54

~g/ml

0

15

75

Norethynodrel - 20 ~g/ml
Hydrocortisone - 20 ~g/ml

0

0

25

0

0

40

~g/ml

Norethynodrel - 20
Hydrocortisone - 20

Norethynodrel - 40

Inoculum:

~g/ml

0.1 ml of a solution containing 10 Klett units of
S. aureus (serotype III).

Incubation:

Rotary shaker at a constant temperature of 37 C.
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TABLE 5

EFFECT OF NORETHYNODREL ON THE GROWTH OF
STAPHYLOCOCCUS AUREUS GROWN PREVIOUSLY
IN TRYPTIC SOY BROTH WITH NORETHYNODREL

Klett reading with inoculum
grown in the absence of
Hours of
growth

Klett reading with inoculum
grown in the presence of

Noreth~odre1

Control

Noreth~odre1

Hormone

Control

Hormone

2

0

0

0

0

4

7

4

5

4

6

57

33

60

31

8

115

75

115

76

Inoculum:

0.1 m1 of a solution containing 10 Klett units of s. aureus
(serotypes IV, V, VI, VIII, IX, XI, XII) which had~een
maintained for 18 hr in broth containing either hormone
or 2% ethanol.

Incubation:

Rotary shaker at a constant temperature of 37 C.

Hormone:

Norethynodrel at a concentration of 40
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~g/ml.

.::

organisms previously grown in the presence of Norethynodrel as compared to
those grown in the presence of the hormone vehicle alone.
In Table 6 the effect of Norethynodrel on anaerobic staphylococcal growth
can be seen.

Single determinations of bacterial density at 24 hr after in-

oculation indicate a striking growth inhibition of S. aureus serotypes II
and III.

In this instance a maximal effect was approximated with a smaller

concentration of Norethynodrel (20

~g

per ml) than was found to be the case

under aerobic conditions.
Clearance studies.

The in vitro growth prompted exploration of the

possible in vivo effects of contraceptive agents.

Table 7 represents the

effect of Enovid administration on the recovery of

~

aureus (serotypes III,

IX and XIII) from selected murine viscera at varying periods after intravenous bacterial challenge.

In both spleen and kidney recovery of viable

organisms was quantitatively reduced in those animals pretreated with Enovid,
for a period encompassing the 6 hr after infection.
tion this effect was still noticeable.

At 18 hr after infec-

Similar clearance studies in mice

revealed no such effect in liver and lung, nor were Norethynodrel or
Mestranol individually capable of suppressing bacterial recovery.
Since it was felt that a decreased ability to recover viable organisms
from viscera of hormone treated animals might be due to a decreased avidity
of the reticuloendothelial system, a study of experimentally induced bacteremia in the rabbit was

underta~en.

In Table 8 it may be seen that with

the exception of the 4 hr reading quantities of viable organisms recoverable
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TABLE 6

EFFECT OF NORETHYNODREL ON THE ANAEROBIC GROWTH OF
STAPHYLOCOCCUS AUREUS

Klett readings with varying hormone concentrations (\-Lg/ml)
Serotype

0

20

40

I

15.0

12.5

10.0

II

51.5

19.0

6.0

III

66.5

15.0

16.5

Inoculum:

1 ml of a solution containing 10 Klett units of S. aureus
(serotypes I, II, III).

Incubation:

In a C02 stationary incubator at 2.5 atmospheres of pressure
and 37 C.

Results:

Average Klett readings with serotypes I, II, and III.
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TABLE 7

FATE OF STAPHYLOCOCCUS AUREUS IN THE SPLEEN AND KIDNEY
OF MICE TREATED WITH ENOVID

Colony forming units per m1 of tissue homogenate
Hours
after
infection

Control

Hormone

Control

Hormone

2

2.9 x 10 6

1.6 x 106

4
3.6 x 10

2.4 x 10

4

3.4 x 10 6

1.5 x 10 6

4.9 x 104

2.3 x 104

6

3.8 x 10

6

1.9 x 106

18

7.4 x 105

4.1 x 105

1.9 x 105
6
3.7 x 10

4
5.1 x .10
6
2.9 x 10

Inoculum:

450 Klett units of

Hormone:

5 ~g Norethynodrel intraperitonea11y for 5 days and 2.5
Mestranol in the same manner. On the day of bacterial
challenge the drugs were administered intravenously in
the same dosage.

Results:

Average of trials utilizing serotypes III, IX, XIII.

Spleen

Kidney

~
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aureus (serotypes III, IX, XIII).
~g

TABLE 8

EFFECT OF ENOVID ON EXPERIMENTALLY INDUCED
BACTEREMIA IN THE RABBIT

Colony forming units per m1 of blood at varying
intervals (hr) after intravenous infection
2

4

6

Control

157

1670

673

Hormone

246

146

755

Group

Inoculum:

1 m1 of a suspension containing 400 Klett units of
aureus, serotype III injected intravenously.

~

Hormone:

Each rabbit received a total of 4000 ~g Norethynodrel
and 150 ~g Mestranol subcutaneously over a period of
10 days.
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from the circulating blood were remarkably similar in both control and
hormone treated animals.
Mortality studies.

These results would be of limited value if they did

not correlate with the clinical response of the host to staphylococcal challenge.

Consequently, hormone treated mice were observed for three days after

infection and the time of their death noted.

The results in Table 9 show

that animals receiving a combination of Norethynodrel and Mestranol suffered
fewer lethal infections on a percentage basis over the period of observation
than did the control group.

This protective action was most noticeable during

the 24 hr immediately following infection when only 1070 of hormone treated
animals died as opposed to 33% of controls.
Blood studies.

Norethynodrel was administered to white female rabbits

in the hope of determining its capacity to modify the total white blood cell
count and differential count, either before or after bacterial challenge.
The results expressed in Table 10 suggest that there was no consistent difference between control and hormone treated animals in this respect.
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~

TABLE 9

EFFECT OF NORETHYNODREL AND MESTRANOL IN COMBINATION ON THE
MORTALITY OF MICE INFECTED WITH STAPHYLOCOCCUS AUREUS

Per cent cumulative mortality
Time (Days)

Hormone

Control

1

10.0

32.8

2

30.0

44.7

3

.55.7

62.8

Inoculum:

450 Klett units of

Hormone:

20 ~g Norethynodrel and 10
period.

Results:

Expressed in percentage of total animals dying at various
periods after intravenous infection.

~

aureus, serotype III.
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~g

Mestranol over a four day

TABLE 10
EFFECT OF NORETHYNODREL ON THE WHITE BLOOD CELL COUNT IN THE RABBIT
Hormone
Group

Control

Total

N

L

Total

N

L

10,025

32

68

~2,640

43

57

Count after Norethynodrel
200 'tlg/5 days

9,675

27

73

13,500

56

44

Count 24 hr after giving
220 Klett units

9,200

64

36

9,200

68

32

N

L

N

L

Blood count before drug
administration

Total

Total

Blood count before drug
administration

7,275

30

70

7,200

52

48

Count after Norethynodrel
4000 'tlg/IO days

8,000

46

54

8,000

41

59

Count 24 hr after giving
300 Klett units

28,850

76

24

16,700

62

38

Method:

All hormone was given subcutaneously.
intravenously.

Results:

Expressed in total white blood cells per cubic ml of blood.
N indicates percentage neutrophils and L percentage lymphocytes.
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Bacteria were given

DISCUSSION
The inhibitory action of Norethynodrel on the growth of staphylococci
is a phenomenon not without experimental precedent.

Similar effects have

been attributed to progesterone (55) and the synthetic progestogen Norethindrone (54).

The mechanism of such effects remains open to speculation.

There is some evidence to indicate the possibility that progestogens, both
natural and synthetic, may interfere with membrane permeability and active
transport (48), and in so doing deprive cells of needed nutrients.

Alterna-

tively, it has been shown that progesterone may slow oxidative processes by
impeding the flow of electrons in the cytochrome system resulting in a decrease of available cellular energy for support of growth and anabolic
processes (24,48,50).

Militating against such conclusions is the fact that

anaerobic growth of S. aureus only served to accentuate the inhibitory effect
of Norethynodrel (Table 5).
An interesting result consistently observed in the present studies was

the manifest tendency of Norethynodrel to quell bacterial proliferation most
efficiently early in the growth cycle, with a rapid subsidence of action
after 8 hr of growth (Table 1).

It must be remembered that at the onset of

growth the concentration per organism of the hormone initially added is a
maximum quantity.

However, variation in the number of organisms in the

initial inoculum did not appear to affect the magnitude of growth inhibition
(Table 2), but only served to produce a simultaneous skewing of the zones

~.

of growth inhibition and the growth curve itself without affecting their
temporal interrelationships.
Cells in the log phase are multiplying at a rapid pace and consequently.
are characterized by accelerated patterns of metabolism -- a critical period
for exposure to metabolic inhibitors and antagonists.

By adding Norethy-

nodrel to varying portions of the growth curve (Table 3) inhibitory effectiveness was found prominent throughout the first 7 hr of growth.

This data

shifts emphasis from the quantity of organisms present to their metabolic
state and activity which at this time is beginning its entrance into the
phase of deceleration of growth.
In addition it is quite possible that such actively metabolizing and
proliferating cells achieve the quantitative ability to modify the hormones
in some way so as to neutralize its antibacterial action.
Finally, it may be adduced that Norethynodrel exerts its effect
throughout the growth curve.

The dwindling difference between hormone

treated and control flasks thus would be attributable not to progressive
failure of hormonal inhibition late in the cycle, but to progressive inhibition of the growth of control organisms in the presence of accumulating
toxic metabolites and depleted stores of nutrient.
does occur to an extent.

Such a phenomena probably

However, the possibility of growth inhibition after

7 hr has been effectively ruled out by the results illustrated in Table 3,·
Characteristically
exposure of staphylococci to Norethynodrel -in vitro
.
.
induces no lasting change since upon reisolation the organisms do not exhibit any alteration in growth patterns or heightened susceptibility to
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subsequent hormonal exposure (Table 5).
twofold.

The significance of such data is

Firstly, the in vitro growth inhibitory effect is readily reversible

Secondly, the ability of the staphylococcus to overcome this inhibitory
effect may not be attributed

~o

the emergence of, or the selection of, org-

anisms possessing a metabolic constitution resistant to the effects of
Norethynodrel.
In vivo experimentation utilizing white female mice revealed a quantitatible reduction in viable organisms recoverable from the spleen and kidney
in those animals pretreated with Enovid (Norethynodrel and Mestranol).
Since the dose, period of administration and time interval following injection have been shown to be of outstanding importance for the effect of hormones on the c6urse of infection (49,52), these factors were carefully
regulated and dosages chosen to approximate on a weight basis those given
to human beings.

Methods of bacterial challenge are equally important,

however, and the course of experimentally induced bacteremia in laboratory
animals has been carefully reviewed by Rogers (38).

Contrary to popular

belief most microbes are less capable of provoking disease when injected
intravenously than when they are administered by any other route.
divides the bacteremia which ensues into 3 phases.

Rogers

The first phase, between

10 min and 5 hr after infection, is characterized by the disappearance of
90 to 99.9% of the circulating bacteria.
4 hr to several days; and

dependi~g

The second phase may last from

on the animal and the pathogen, micro-

organisms may persist in the circulation at lower concentrations or be
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removed at slower rates.

During the third phase bacteria producing fatal

infections reappear in the peripheral blood in large quantities and persist
until the death of the animal.

In the event of survival there may be a

temporary rise in blood levels of bacteria with subsequent complete clearance.

The virulence of the organisms in question largely governs the late

blood findings.
Certain cells of the reticuloendothelial system, the

~upffer

cells

lining liver capillaries and phagocytic cells in splenic sinuses, are the
most important sites of initial clearance of bacteria (7).

Microbes are

removed at a constant rate characteristic for the bacteria and the uptake
by organs is related in a definite manner to their disappearance from the
bloodstream.

It is during this first phase of bacteremia that Norethynodrel

was found effective in reducing the quantity of recoverable organisms in
spleen and kidney (Table 8).

In view of what has been said above such a

phenomenon could be due to an increased avidity of the blood for the organisms, decreased uptake by the fixed phagocytes of the reticuloendothelial
system or a more rapid killing of ingested organisms by the phagocytizing
cell.
Several workers have found that pathogenic staphylococci possess the
capability to remain viable within phagocytes for several hours after ingestion (39,42,43).
the

fi~st

A differential effect due to intracellular killing within

2 hr of infection would .appear unlikely •. Studies on levels of

bacteremia in rabbits as well as total white blood cell counts and

~.

~

differential counts have consistently revealed no difference between rabbits
treated with hormone and control animals (Tables 9, 10).

Thus it would

appear that phagocytic ability of the white blood cell has not been altered
either quantitatively (4) or qualitatively.
Decreased phagocytic ability of the fixed phagocytes of the reticuloendothelial system is a possible explanation.

However, the mechanism of

such an action or why it should selectively affect only cells of the spleen
and kidney is obscure and could be dependent on local humoral or anatomic
factors.

Although during phagocytosis by leucocytes there is a large in-

crease in the oxygen uptake, most of this does not yield energy for the
process of ingestion (36).

In fact, Brogan has shown that the serum inde-

pendent mechanism of phagocytosis relies almost completely on glycolytic
energy (8).

Thus demonstrated effects of progesterone on electron transport

may not be invoked as an explanation here (50,53).
Whatever the mechanism, the end result is apparently a decreased
mortality in mice protected by hormone (Table 8).

Experimental evidence

suggests that bacteremia persists or resurges into the "third phase" only
when there is active seeding of the bloodstream (38).

There is some indi-

cation that certain bacteria may reseed the circulation from the reticuloendothelial tissues in which they are originally sequestered.

If indeed such

sequestration is prohibited, or if sequestered organisms are rendered nonviab1e.then it might reasonably

b~

expected that reseeding and mortal dis-

semination could be delayed or prevented.
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Decreased deposition and

proliferation of pathogenic organisms in vital organs such as the kidney
may prolong life by decreasing the probability of resurgent bacteremia and
the likelihood of destruction of renal tissue necessary for the maintenance
of life.

~.

SUMMARY

The effect of Norethynodrel on the growth of S. aureus was studied
in vitro; and the effect of the combination of drugs, Norethynodrel and
Mestranol (Enovid) on the course of in vivo bacteremia was determined.

The

results may be summarized in the following manner:
1.

Norethynodrel inhibits the growth of a variety of serotypes of

S. aureus in vitro.
2.

This effect is most marked in the lag phase of growth but persists

well into the exponential portion of the growth curve.
3.

Hydrocortisone and Norethynodrel in combination were able to pro-

duce a greater degree of growth suppression than either drug alone.
4.

Growth in a C02 atmosphere potentiates the inhibitory effect of .

Norethynodrel.
5.

The combination of Norethynodrel and Mestranol reduces the viable

organisms recoverable from the spleen and kidney of hematogenously infected
mice.

40.
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